» Articles » PMID: 25918478

Evasion of Early Antiviral Responses by Herpes Simplex Viruses

Overview
Publisher Wiley
Specialties Biochemistry
Pathology
Date 2015 Apr 29
PMID 25918478
Citations 32
Authors
Affiliations
Soon will be listed here.
Abstract

Besides overcoming physical constraints, such as extreme temperatures, reduced humidity, elevated pressure, and natural predators, human pathogens further need to overcome an arsenal of antimicrobial components evolved by the host to limit infection, replication and optimally, reinfection. Herpes simplex virus-1 (HSV-1) and herpes simplex virus-2 (HSV-2) infect humans at a high frequency and persist within the host for life by establishing latency in neurons. To gain access to these cells, herpes simplex viruses (HSVs) must replicate and block immediate host antiviral responses elicited by epithelial cells and innate immune components early after infection. During these processes, infected and noninfected neighboring cells, as well as tissue-resident and patrolling immune cells, will sense viral components and cell-associated danger signals and secrete soluble mediators. While type-I interferons aim at limiting virus spread, cytokines and chemokines will modulate resident and incoming immune cells. In this paper, we discuss recent findings relative to the early steps taking place during HSV infection and replication. Further, we discuss how HSVs evade detection by host cells and the molecular mechanisms evolved by these viruses to circumvent early antiviral mechanisms, ultimately leading to neuron infection and the establishment of latency.

Citing Articles

A review of HSV pathogenesis, vaccine development, and advanced applications.

Bai L, Xu J, Zeng L, Zhang L, Zhou F Mol Biomed. 2024; 5(1):35.

PMID: 39207577 PMC: 11362470. DOI: 10.1186/s43556-024-00199-7.


Asymptomatic herpes simplex virus brain infection elicits cellular senescence phenotypes in the central nervous system of mice suffering multiple sclerosis-like disease.

Duarte L, Villalobos V, Farias M, Rangel-Ramirez M, Gonzalez-Madrid E, Navarro A Commun Biol. 2024; 7(1):811.

PMID: 38965360 PMC: 11224417. DOI: 10.1038/s42003-024-06486-x.


Heme Oxygenase-1 Expression in Dendritic Cells Contributes to Protective Immunity against Herpes Simplex Virus Skin Infection.

Tognarelli E, Duarte L, Farias M, Cancino F, Corrales N, Ibanez F Antioxidants (Basel). 2023; 12(6).

PMID: 37371900 PMC: 10294886. DOI: 10.3390/antiox12061170.


The Effect of Electrical Stimulation Therapy on Brain Derived Neurotrophic Factor in Patients with Tinnitus.

Meybodian M, Mahmoodifar S, Mandegari M, Baradaranfar M, Dadgarnia M, Vaziribozorg S Indian J Otolaryngol Head Neck Surg. 2023; 75(Suppl 1):498-501.

PMID: 37206826 PMC: 10188857. DOI: 10.1007/s12070-022-03417-2.


Blue light irradiation exerts anti-viral and anti-inflammatory properties against herpes simplex virus type 1 infection.

Oh P, Han Y, Lim S, Jeong H J Photochem Photobiol B. 2023; 239:112632.

PMID: 36608399 PMC: 9771843. DOI: 10.1016/j.jphotobiol.2022.112632.


References
1.
Xu F, Sternberg M, Kottiri B, McQuillan G, Lee F, Nahmias A . Trends in herpes simplex virus type 1 and type 2 seroprevalence in the United States. JAMA. 2006; 296(8):964-73. DOI: 10.1001/jama.296.8.964. View

2.
Belshe R, Leone P, Bernstein D, Wald A, Levin M, Stapleton J . Efficacy results of a trial of a herpes simplex vaccine. N Engl J Med. 2012; 366(1):34-43. PMC: 3287348. DOI: 10.1056/NEJMoa1103151. View

3.
Belshe R, Heineman T, Bernstein D, Bellamy A, Ewell M, van der Most R . Correlate of immune protection against HSV-1 genital disease in vaccinated women. J Infect Dis. 2013; 209(6):828-36. PMC: 3935479. DOI: 10.1093/infdis/jit651. View

4.
Li H, Zhang J, Kumar A, Zheng M, Atherton S, Yu F . Herpes simplex virus 1 infection induces the expression of proinflammatory cytokines, interferons and TLR7 in human corneal epithelial cells. Immunology. 2006; 117(2):167-76. PMC: 1782219. DOI: 10.1111/j.1365-2567.2005.02275.x. View

5.
Yamauchi Y, Daikoku T, Goshima F, Nishiyama Y . Herpes simplex virus UL14 protein blocks apoptosis. Microbiol Immunol. 2003; 47(9):685-9. DOI: 10.1111/j.1348-0421.2003.tb03432.x. View